|
name | 周宏富 |
|
sex | male
|
|
age | 80 岁 |
|
hospital number | 517854 |
|
height | 176 cm |
|
weight | 60 kg |
|
BSA | 1.74 m2 |
|
APACHEⅡ | 22 分 |
|
Infection source | abdominal
|
|
date | 2017/07/05 年/月/日 |
|
Sequential Organ Failure Assessment | 20 分 |
|
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
|
|
age>=60 | yes
|
|
septic shock | yes
|
|
mechanical ventilation | trachea cannula
|
|
Early fluid resuscitation | yes
|
|
age<60 | no
|
|
Pregnant woman | no
|
|
advanced malignant tumor | no
|
|
Pulmonary interstitial fibrosis | no
|
|
Serious arrhythmia | no
|
|
Small Tidal Volume Ventilation | no
|
|
Liver failure | no
|
|
Refuse to participate | no
|
|
Heart disease | |
yes
|
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
泰能+斯沃 |
|
|
vasoactive agent | norepinephrine
|
30 min |
|
min |
|
30 min |
|
Temperature | 36.9 ℃ |
|
Heart Rate | 123 次/分 |
|
Breath | 26 次/分 |
|
Systolic pressure (SP) | 136 mmHg |
|
Diastolic pressure | 61 mmHg |
|
mean arterial pressure | 86 mmHg |
|
Pcv-aCO2 | 12.3 mmHg |
|
DO2 | 759.8 |
|
VO2 | 256.5 |
|
Ca-vO2 | 53.3 |
|
pH value | 7.31 |
|
PaO2 | 128.6 mmHg |
|
PaCO2 | 30.7 mmHg |
|
BE | -9.6 mmol/L(±2.3mmol/L) |
|
SaO2 | 98 % |
|
Blood lactic acid concentration, LAC | 4.5 mmol/L |
|
Oxygenation index (PaO2/FiO2) | 285.8 mmHg |
|
pH value | 7.30 |
|
PcvO2 | 42 mmHg |
|
PcvCO2 | 43 mmHg |
|
BE | -10.6 mmol/L |
|
ScvO2 | 65 % |
|
Volume of input | 0 ml |
|
Volume of output | 0 ml |
|
Volume of urine | 0 ml |
|
ultrafiltration volume | 0 ml |
|
norepinephrine | yes
|
|
Norepinephrine Dosage | 0.75 μg/Kg/min |
|
dopamine | no
|
|
Dopamine Dosage | μg/Kg/min |
|
Dobutamine | No
|
|
Dobutamine Dosage | μg/Kg/min |
|
CVP | 3 mmHg |
|
cardiac output | 4.81 L/min |
|
cardiac index | 2.76 L/min/m2 |
|
stroke volume | 39.1 ml |
|
Stroke Index | 22.5 ml/m2 |
|
ITBVI | 999 ml/m2 |
|
GEDVI | 794 ml/m2 |
|
EVLWI | 6.7 ml/kg |
|
PVPI | 1.2 |
|
SVRI | 1880 DSm2/cm5 |
|
CFI | 3.2 |
|
GEF | 11 % |
|
SVV | 28 % |
|
PPV | % |
|
dPmax | 905 |
|
LVEF | % |
|
FS | % |
|
SV | ml |
|
CO | L/min |
|
E peak |
|
|
A peak |
|
|
E/A |
|
|
Ea(ventricular septum) |
|
|
Ea(lateral wall) |
|
|
E/Ea(ventricular septum) |
|
|
E/Ea(lateral wall) |
|
|
MAPSE | mm |
|
TAPSE | mm |
|
RV size | |
|
LVEDV | ml |
|
LVEDD | cm |
|
the number of B line | 4 条 |
|
LUS | 分 |
|
B+ Zone | 区 |
|
IVC(inspiratory phase) | 1.2 mm |
|
IVC(expiratory phase) | 1.6 mm |
|
respiratory variations of inferior vena cavae diameter | 28 % |
1.2 mm |
|
mm |
|
1.65 mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
|
IVC(inspiratory phase) | 1.4 mm |
|
IVC(expiratory phase) | 1.6 mm |
|
Respiratory variations of inferior vena cavae diameter | 13 % |
1.6 mm |
|
mm |
|
1.8 mm |
|
mm |
|
Temperature | 37.5 ℃ |
|
Heart Rate | 130 次/分 |
|
Breath | 20 次/分 |
|
Systolic Pressure | 100 mmHg |
|
Diastolic Pressure | 55 mmHg |
|
Mean Arterial Pressure | 66 mmHg |
|
Pcv-aCO2 | 11.7 mmHg |
|
DO2 | 843.2 |
|
VO2 | 269.9 |
|
Ca-vO2 | 47.9 |
|
PH value | 7.27 |
|
PaO2 | 97 mmHg |
|
PaCO2 | 28.3 mmHg |
|
BE | -12.6 mmol/L |
|
SaO2 | 97 % |
|
Blood Lactic Acid Concentration | 7.9 mmol/L |
|
Oxygenation index (PaO2/FiO2) | 215.6 mmHg |
|
PH value | 7.25 |
|
PcvO2 | 39 mmHg |
|
PcvCO2 | 40 mmHg |
|
BE | -13 mmol/L |
|
ScvO2 | 66 % |
|
Volume of input | 2450 ml |
|
Volume of output | 800 ml |
|
Volume of urine | 0 ml |
|
Ultrafiltration Volume | ml |
|
Norepinephrine Dosage | 16.2 mg |
|
Dopamine Dosage | mg |
|
Epinephrine Dosage | mg |
|
Pituitrin Dosage | U |
|
Dobutamine Dosage | mg |
|
Milrinone Dosage | mg |
|
Levosimendan | no
|
|
CVP | 7 mmHg |
|
cardiac output | 5.63 L/min |
|
cardiac index | 3.24 L/min/m2 |
|
stroke volume | 43.3 ml |
|
Stroke Index | 24.9 ml/m2 |
|
ITBVI | 1078 ml/m2 |
|
GEDVI | 862 ml/m2 |
|
EVLWI | 7.6 ml/kg |
|
PVPI | 1.3 |
|
SVRI | 1878 DSm2/cm5 |
|
CFI | 3.5 |
|
GEF | 10 % |
|
SVV | % |
|
PPV | % |
|
dPmax | 1483 |
|
LVEF | % |
|
FS | % |
|
SV | ml |
|
CO | L/min |
|
E peak |
|
|
A peak |
|
|
E/A |
|
|
Ea(ventricular septum) |
|
|
Ea(lateral wall) |
|
|
E/Ea(ventricular septum) |
|
|
E/Ea(lateral wall) |
|
|
MAPSE | mm |
|
TAPSE | mm |
|
RV size | |
|
LVEDV | ml |
|
LVEDD | cm |
|
The number of B line | 4 条 |
|
LUS | 分 |
|
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
|
Temperature | 38 ℃ |
|
Heart Rate | 132 次/分 |
|
Breath | 20 次/分 |
|
Systolic Pressure | 130 mmHg |
|
Diastolic Pressure | 71 mmHg |
|
Mean Arterial Pressure | 92 mmHg |
|
Pcv-aCO2 | 9.8 mmHg |
|
DO2 | 1253.8 |
|
VO2 | 372.7 |
|
Ca-vO2 | 45.7 |
|
PH value | 7.53 |
|
PaO2 | 107.3 mmHg |
|
PaCO2 | 32.1 mmHg |
|
BE | -8 mmol/L |
|
SaO2 | 97.8 % |
|
Blood Lactic Acid Concentration | 2.7 mmol/L |
|
Oxygenation index (PaO2/FiO2) | 238.4 mmHg |
|
PH value | 7.27 |
|
PcvO2 | 36.6 mmHg |
|
PcvCO2 | 41.9 mmHg |
|
BE | -7.7 mmol/L |
|
ScvO2 | 68.8 % |
|
Volume of input | 4900 ml |
|
Volume of output | 1535 ml |
|
Volume of urine | 200 ml |
|
Ultrafiltration Volume | ml |
|
Norepinephrine Dosage | 32.4 mg |
|
Dopamine Dosage | mg |
|
Epinephrine Dosage | mg |
|
Pituitrin Dosage | U |
|
Dobutamine Dosage | mg |
|
Milrinone Dosage | mg |
|
Levosimendan |
|
CVP | 1 mmHg |
|
cardiac output | 8.16 L/min |
|
cardiac index | 4.69 L/min/m2 |
|
stroke volume | 61.8 ml |
|
Stroke Index | 4.69 ml/m2 |
|
ITBVI | 975 ml/m2 |
|
GEDVI | 780 ml/m2 |
|
EVLWI | 7.0 ml/kg |
|
PVPI | 1.3 |
|
SVRI | 1500 DSm2/cm5 |
|
CFI | 5.6 |
|
GEF | 16 % |
|
SVV | 10 % |
|
PPV | % |
|
dPmax | 1435 |
|
LVEF | % |
|
FS | % |
|
SV | ml |
|
CO | L/min |
|
E peak |
|
|
A peak |
|
|
E/A |
|
|
Ea(ventricular septum) |
|
|
Ea(lateral wall) |
|
|
E/Ea(ventricular septum) |
|
|
E/Ea(lateral wall) |
|
|
MAPSE | mm |
|
TAPSE | mm |
|
RV size | |
|
LVEDV | ml |
|
LVEDD | cm |
|
The number of B line | 12 条 |
|
LUS | 分 |
|
B+ Zone | 区 |
|
IVC(inspiratory phase) | 1.4 mm |
|
IVC(expiratory phase) | 1.8 mm |
|
Respiratory variations of inferior vena cavae diameter | 15 % |
1.4 mm |
|
mm |
|
1.8 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
|
Temperature | 38.5 ℃ |
|
Heart Rate | 138 次/分 |
|
Breath | 16 次/分 |
|
Systolic Pressure | 141 mmHg |
|
Diastolic Pressure | 81 mmHg |
|
Mean Arterial Pressure | 111 mmHg |
|
Pcv-aCO2 | 9.1 mmHg |
|
DO2 | 1147.9 |
|
VO2 | 274.7 |
|
Ca-vO2 | 33.4 |
|
PH value | 7.31 |
|
PaO2 | 96 mmHg |
|
PaCO2 | 23.5 mmHg |
|
BE | -12.9 mmol/L |
|
SaO2 | 97.2 % |
|
Blood Lactic Acid Concentration | 4.4 mmol/L |
|
Oxygenation index (PaO2/FiO2) | 213.3 mmHg |
|
PH value | 7.27 |
|
PcvO2 | 40.8 mmHg |
|
PcvCO2 | 32.6 mmHg |
|
BE | -11.3 mmol/L |
|
ScvO2 | 74.0 % |
|
Volume of input | 6500 ml |
|
Volume of output | 2050 ml |
|
Volume of urine | 400 ml |
|
Ultrafiltration Volume | ml |
|
Norepinephrine Dosage | 65 mg |
|
Dopamine Dosage | mg |
|
Epinephrine Dosage | mg |
|
Pituitrin Dosage | U |
|
Dobutamine Dosage | mg |
|
Milrinone Dosage | mg |
|
Levosimendan |
|
CVP | 6 mmHg |
|
cardiac output | 8.22 L/min |
|
cardiac index | 4.72 L/min/m2 |
|
stroke volume | 59.6 ml |
|
Stroke Index | 34.2 ml/m2 |
|
ITBVI | 1103 ml/m2 |
|
GEDVI | 882 ml/m2 |
|
EVLWI | 8.0 ml/kg |
|
PVPI | 1.4 |
|
SVRI | 1794 DSm2/cm5 |
|
CFI | 5.0 |
|
GEF | 14 % |
|
SVV | 14 % |
|
PPV | % |
|
dPmax | 1359 |
|
LVEF | % |
|
FS | % |
|
SV | ml |
|
CO | L/min |
|
E peak |
|
|
A peak |
|
|
E/A |
|
|
Ea(ventricular septum) |
|
|
Ea(lateral wall) |
|
|
E/Ea(ventricular septum) |
|
|
E/Ea(lateral wall) |
|
|
MAPSE | mm |
|
TAPSE | mm |
|
RV size | |
|
LVEDV | ml |
|
LVEDD | cm |
|
The number of B line | 12 条 |
|
LUS | 分 |
|
B+ Zone | 区 |
|
IVC(inspiratory phase) | 1.6 mm |
|
IVC(expiratory phase) | 2.0 mm |
|
Respiratory variations of inferior vena cavae diameter | 22 % |
1.5 mm |
|
mm |
|
1.9 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
|
Temperature | 38.3 ℃ |
|
Heart Rate | 150 次/分 |
|
Breath | 18 次/分 |
|
Systolic Pressure | 101 mmHg |
|
Diastolic Pressure | 71 mmHg |
|
Mean Arterial Pressure | 84 mmHg |
|
Pcv-aCO2 | 4.8 mmHg |
|
DO2 | 696.5 |
|
VO2 | 199.6 |
|
Ca-vO2 | 33.2 |
|
PH value | 7.41 |
|
PaO2 | 112.2 mmHg |
|
PaCO2 | 33.7 mmHg |
|
BE | -3.0 mmol/L |
|
SaO2 | 98 % |
|
Blood Lactic Acid Concentration | 0.9 mmol/L |
|
Oxygenation index (PaO2/FiO2) | 249.3 mmHg |
|
PH value | 7.38 |
|
PcvO2 | 50 mmHg |
|
PcvCO2 | 38.5 mmHg |
|
BE | -3.2 mmol/L |
|
ScvO2 | 70 % |
|
Volume of input | 8914 ml |
|
Volume of output | 5431 ml |
|
Volume of urine | 2300 ml |
|
Ultrafiltration Volume | ml |
|
Norepinephrine Dosage | 97.5 mg |
|
Dopamine Dosage | mg |
|
Epinephrine Dosage | mg |
|
Pituitrin Dosage | U |
|
Dobutamine Dosage | 180 mg |
|
Milrinone Dosage | mg |
|
Levosimendan |
|
CVP | 15 mmHg |
|
cardiac output | 6.01 L/min |
|
cardiac index | 3.45 L/min/m2 |
|
stroke volume | 40.1 ml |
|
Stroke Index | 34.2 ml/m2 |
|
ITBVI | 1265 ml/m2 |
|
GEDVI | 10112 ml/m2 |
|
EVLWI | 7.5 ml/kg |
|
PVPI | 1.1 |
|
SVRI | 1759 DSm2/cm5 |
|
CFI | 3.2 |
|
GEF | 9 % |
|
SVV | % |
|
PPV | % |
|
dPmax |
|
|
LVEF | % |
|
FS | % |
|
SV | ml |
|
CO | L/min |
|
E peak |
|
|
A peak |
|
|
E/A |
|
|
Ea(ventricular septum) |
|
|
Ea(lateral wall) |
|
|
E/Ea(ventricular septum) |
|
|
E/Ea(lateral wall) |
|
|
MAPSE | mm |
|
TAPSE | mm |
|
RV size | |
|
LVEDV | ml |
|
LVEDD | cm |
|
The number of B line | 16 条 |
|
LUS | 分 |
|
B+ Zone | 区 |
|
IVC(inspiratory phase) | 1.6 mm |
|
IVC(expiratory phase) | 2.0 mm |
|
Respiratory variations of inferior vena cavae diameter | 22 % |
1.7 mm |
|
mm |
|
2.0 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
|
Temperature | 38 ℃ |
|
Heart Rate | 86 次/分 |
|
Breath | 16 次/分 |
|
Systolic Pressure | 133 mmHg |
|
Diastolic Pressure | 71 mmHg |
|
Mean Arterial Pressure | 101 mmHg |
|
Pcv-aCO2 | 5.3 mmHg |
|
DO2 | 644.5 |
|
VO2 | 150.8 |
|
Ca-vO2 | 27.7 |
|
PH value | 7.45 |
|
PaO2 | 103.1 mmHg |
|
PaCO2 | 34.7 mmHg |
|
BE | -1.1 mmol/L |
|
SaO2 | 97.8 % |
|
Blood Lactic Acid Concentration | 2.2 mmol/L |
|
Oxygenation index (PaO2/FiO2) | 229.1 mmHg |
|
PH value | 7.41 |
|
PcvO2 | 44 mmHg |
|
PcvCO2 | 40 mmHg |
|
BE | -1.2 mmol/L |
|
ScvO2 | 75 % |
|
Volume of input | 13300 ml |
|
Volume of output | 7476 ml |
|
Volume of urine | 4800 ml |
|
Ultrafiltration Volume | ml |
|
Norepinephrine Dosage | 97.5 mg |
|
Dopamine Dosage | mg |
|
Epinephrine Dosage | mg |
|
Pituitrin Dosage | U |
|
Dobutamine Dosage | 360 mg |
|
Milrinone Dosage | mg |
|
Levosimendan |
|
CVP | 12 mmHg |
|
cardiac output | 5.45 L/min |
|
cardiac index | 3.13 L/min/m2 |
|
stroke volume | 63.4 ml |
|
Stroke Index | 36.4 ml/m2 |
|
ITBVI | 13.8 ml/m2 |
|
GEDVI | 1055 ml/m2 |
|
EVLWI | 8.6 ml/kg |
|
PVPI | 1.2 |
|
SVRI | 2553 DSm2/cm5 |
|
CFI | 2.7 |
|
GEF | 12 % |
|
SVV | 5 % |
|
PPV | % |
|
dPmax | 1255 |
|
LVEF | % |
|
FS | % |
|
SV | ml |
|
CO | L/min |
|
E peak |
|
|
A peak |
|
|
E/A |
|
|
Ea(ventricular septum) |
|
|
Ea(lateral wall) |
|
|
E/Ea(ventricular septum) |
|
|
E/Ea(lateral wall) |
|
|
MAPSE | mm |
|
TAPSE | mm |
|
RV size | |
|
LVEDV | ml |
|
LVEDD | cm |
|
The number of B line | 28 条 |
|
LUS | 分 |
|
B+ Zone | 区 |
|
IVC(expiratory phase) | 1.8 mm |
|
Respiratory variations of inferior vena cavae diameter | 2.0 % |
|
IVC(inspiratory phase) | 10 mm |
1.8 mm |
|
mm |
|
2.0 mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
|
NT-proBNP | pg/ml |
|
BNP | 243 pg/ml |
|
cTNI | ng/ml |
|
Creatine kinase isoenzyme, CKMB | U/L |
|
Creatinine | 103 umol/L |
|
Urea nitrogen | 10.9 mmol/l |
|
MDRD | ml/min/1.73m2 |
|
Date of examination | yyyy-mm-dd |
|
WBC | 2.1 X10*9/L |
|
neutrophilic granulocyte percentage | 70.8 % |
|
Hb | 120 g/L |
|
CRP | 86.78 mg/L |
|
Procalcitonin, PCT | >100 ng/ml |
|
Date of test |
|
|
Sequential Organ Failure Assessment | 20 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
|
NT-proBNP | pg/ml |
|
BNP | 153 pg/ml |
|
cTNI | ng/ml |
|
Creatine kinase isoenzyme, CKMB | U/L |
|
Creatinine | 115 umol/L |
|
Urea nitrogen | 13.9 mmol/l |
|
MDRD | ml/min/1.73m2 |
|
WBC | 15.9 X10*9/L |
|
neutrophilic granulocyte percentage | 96.5 % |
|
Hb | 107 g/L |
|
CRP | 300.5 mg/L |
|
Procalcitonin, PCT | >100 ng/ml |
|
Sequential Organ Failure Assessment | 17 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
|
NT-proBNP | pg/ml |
|
BNP | 565 pg/ml |
|
cTNI | ng/ml |
|
Creatine kinase isoenzyme, CKMB | U/L |
|
Creatinine | 121 umol/L |
|
Urea nitrogen | 13.4 mmol/L |
|
MDRD | ml/min/1.73m2 |
|
WBC | 16.6 X10*9/L |
|
neutrophilic granulocyte percentage | 96.6 % |
|
Hb | 88 g/L |
|
CRP | 285.5 mg/L |
|
Procalcitonin, PCT | >100 ng/ml |
|
Sequential Organ Failure Assessment | 15 分 |
|
Transfusion of Red Cells | no
|
|
Transfusion of Red Cells | U |
|
Plasma infusion | yes
|
|
Plasma infusion | 1500 ml |
|
platelet transfusion | no
|
|
platelet transfusion | U |
|
APACHEⅡ | 14 分 |
|
Complication |
|
prognosis | department transference
|
|
28-day mortality | no
|
|
survival time(day) | 天 |
|
death time | yyyy/mm/dd |
|
diagnosis of death |
|
|
length of stay | 天 |
|
duration in ICU | 16 天 |
|
duration of mechanical ventilation | 312 小时 |
|
ICU expenses | 191878 元 |
|
Continuous Renal Replacement Therapy | no
|
|
Continuous Renal Replacement Therapy | 小时 |




